FindTrial
Sign In

125I seed-loaded stents versus 125I seed-strips in the treatment of unresectable malignant obstructive jaundice

125I seed-loaded stents versus 125I seed-strips in the treatment of unresectable malignant obstructive jaundice

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015807
Enrollment
Unknown
Registered
2018-04-22
Start date
2015-05-01
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bile duct disease

Interventions

125I seed-loaded stents:Stent placement
125I seed-strips:125I seed-strips placement

Sponsors

The First Hospital of Lanzhou University Intervention Department
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1) unresectable malignant biliary stricture due to extensive lesions, metastases, or poor medical condition; 2) clear consciousness and cooperation; 3) Bismuth-Corlette type I, II or III; and 4) an Eastern Cooperative Oncology Group (ECOG) performance status score of 0–3.

Exclusion criteria

Exclusion criteria: 1) benign biliary obstruction; 2) Bismuth-Corlette type IV; 3) ECOG performance status of 4; 4) non-cooperation; 5) receipt of beam radiotherapy or radiofrequency therapy; and 6) ablation renal inadequacy.

Design outcomes

Primary

MeasureTime frame
Total bilirubin levels;quality of life;???;biliary obstruction-free time;—

Countries

China

Contacts

Public ContactWebhui Wang

The First Hospital of Lanzhou University Intervention Department

470090101@qq.com+86 13919843357

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026